Skip to results
1-10 of 10
Authors: Alexandra Scherrer
Sort by
Journal Article
Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group Free
Huyen Nguyen and others
Clinical Infectious Diseases, Volume 74, Issue 12, 15 June 2022, Page 2266, https://doi.org/10.1093/cid/ciac242
Published: 27 April 2022
Journal Article
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study Free
Bernadette Jakeman and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 2, February 2022, Pages 492–499, https://doi.org/10.1093/jac/dkab386
Published: 03 November 2021
Journal Article
Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group
Get access
Huyen Nguyen and others
Clinical Infectious Diseases, Volume 74, Issue 8, 15 April 2022, Pages 1468–1475, https://doi.org/10.1093/cid/ciab628
Published: 20 July 2021
Journal Article
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus Free
Lauren Greenberg and others
Clinical Infectious Diseases, Volume 73, Issue 7, 1 October 2021, Pages e2323–e2333, https://doi.org/10.1093/cid/ciaa1878
Published: 23 December 2020
Journal Article
Real-life management of drug–drug interactions between antiretrovirals and statins Free
Perrine Courlet and others
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1972–1980, https://doi.org/10.1093/jac/dkaa099
Published: 02 April 2020
Journal Article
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients Open Access
Flaminia Olearo and others
Open Forum Infectious Diseases, Volume 6, Issue 12, December 2019, ofz500, https://doi.org/10.1093/ofid/ofz500
Published: 08 December 2019
Journal Article
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients Open Access
Flaminia Olearo and others
Open Forum Infectious Diseases, Volume 6, Issue 10, October 2019, ofz330, https://doi.org/10.1093/ofid/ofz330
Published: 12 July 2019
Journal Article
Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery
Get access
Frederik N. Engsig and others
Clinical Infectious Diseases, Volume 58, Issue 9, 1 May 2014, Pages 1312–1321, https://doi.org/10.1093/cid/ciu038
Published: 22 January 2014
Journal Article
The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post–Combination Antiretroviral Therapy Era
Get access
A. Mocroft and others
Clinical Infectious Diseases, Volume 57, Issue 7, 1 October 2013, Pages 1038–1047, https://doi.org/10.1093/cid/cit423
Published: 06 August 2013
Journal Article
Predictors of CD4+ T-Cell Counts of HIV Type 1–Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes
Get access
The Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) and others
The Journal of Infectious Diseases, Volume 207, Issue 5, 1 March 2013, Pages 759–767, https://doi.org/10.1093/infdis/jis752
Published: 07 December 2012